Literature DB >> 29949179

Tumor microenvironment: recent advances in various cancer treatments.

J-J Wang1, K-F Lei, F Han.   

Abstract

This is a review regarding different types of cancer treatments. We aimed at analyzing the tumor microenvironment and the recent trends for the therapeutic applications and effectiveness for several kinds of cancers. Traditionally the cancer treatment was based on the neoplastic cells. Methods such as surgery, radiation, chemotherapy, and immunotherapy, which were targeted on the highly proliferating mutated tumor cells, have been investigated. The tumor microenvironment describes the non-cancerous cells in the tumor and has enabled to investigate the behavior and response of the cancer cells to a treatment process; it consists in a tissue that may have a predictive significance for tumor behavior and response to therapy. These include fibroblasts, immune cells and cells that comprise the blood vessels. It also includes the proteins produced by all of the cells present in the tumor that support the growth of the cancer cells. By monitoring changes in the tumor microenvironment using its molecular and cellular profiles as the tumor progresses will be vital for identifying cell or protein targets for the cancer prevention and its therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29949179     DOI: 10.26355/eurrev_201806_15270

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  68 in total

1.  LncRNA MAPKAPK5_AS1 facilitates cell proliferation in hepatitis B virus -related hepatocellular carcinoma.

Authors:  Lianyuan Tao; Deyu Li; Sengmao Mu; Guanjing Tian; Guoyi Yan
Journal:  Lab Invest       Date:  2022-03-09       Impact factor: 5.662

Review 2.  Kinetics of Nanomedicine in Tumor Spheroid as an In Vitro Model System for Efficient Tumor-Targeted Drug Delivery With Insights From Mathematical Models.

Authors:  Sayoni Maitra Roy; Vrinda Garg; Sourav Barman; Chitrita Ghosh; Amit Ranjan Maity; Surya K Ghosh
Journal:  Front Bioeng Biotechnol       Date:  2021-12-01

3.  Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid Tumors.

Authors:  Brian T Welsh; Ryan Faucette; Sanela Bilic; Constance J Martin; Thomas Schürpf; David Chen; Samantha Nicholls; Janice Lansita; Ashish Kalra
Journal:  Int J Toxicol       Date:  2021-03-19       Impact factor: 2.032

Review 4.  A Systematic Review of the Role of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in the Treatment of Solid Tumors.

Authors:  Raheel S Siddiqui; Muhammad Sardar
Journal:  Cureus       Date:  2021-04-15

5.  Immune Infiltrates of m6A RNA Methylation-Related lncRNAs and Identification of PD-L1 in Patients With Primary Head and Neck Squamous Cell Carcinoma.

Authors:  Zi-Yi Feng; Hao-Yu Gao; Tian-Da Feng
Journal:  Front Cell Dev Biol       Date:  2021-06-04

Review 6.  "Present and future of immunotherapy in Neuroendocrine Tumors".

Authors:  Manuela Albertelli; Andrea Dotto; Federica Nista; Alessandro Veresani; Luca Patti; Stefano Gay; Stefania Sciallero; Mara Boschetti; Diego Ferone
Journal:  Rev Endocr Metab Disord       Date:  2021-04-14       Impact factor: 9.306

Review 7.  LncRNA as a multifunctional regulator in cancer multi-drug resistance.

Authors:  Jiaying He; Shaomi Zhu; Xin Liang; Qinxiu Zhang; Xiaohong Luo; Chi Liu; Linjiang Song
Journal:  Mol Biol Rep       Date:  2021-07-31       Impact factor: 2.316

8.  Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma.

Authors:  Wenjing Song; Xin He; Pengju Gong; Yan Yang; Sirui Huang; Yifan Zeng; Lei Wei; Jingwei Zhang
Journal:  Front Genet       Date:  2021-06-23       Impact factor: 4.599

Review 9.  Radiogenomics in brain, breast, and lung cancer: opportunities and challenges.

Authors:  Apurva Singh; Rhea Chitalia; Despina Kontos
Journal:  J Med Imaging (Bellingham)       Date:  2021-06-18

10.  P2RY14 Is a Potential Biomarker of Tumor Microenvironment Immunomodulation and Favorable Prognosis in Patients With Head and Neck Cancer.

Authors:  Qingxiang Li; Le Xu; Yuke Li; Rong Yang; Qiao Qiao; Yifei Wang; Lin Wang; Yuxing Guo; Chuanbin Guo
Journal:  Front Genet       Date:  2021-07-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.